1463 related articles for article (PubMed ID: 28786561)
1. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
[TBL] [Abstract][Full Text] [Related]
2. The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.
Khalil MI; Yang C; Vu L; Chadha S; Nabors H; James CD; Morgan IM; Pyeon D
J Virol; 2024 Feb; 98(2):e0172623. PubMed ID: 38226814
[TBL] [Abstract][Full Text] [Related]
3. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells.
Rampias T; Boutati E; Pectasides E; Sasaki C; Kountourakis P; Weinberger P; Psyrri A
Mol Cancer Res; 2010 Mar; 8(3):433-43. PubMed ID: 20215420
[TBL] [Abstract][Full Text] [Related]
4. Docosahexaenoic acid induces the degradation of HPV E6/E7 oncoproteins by activating the ubiquitin-proteasome system.
Jing K; Shin S; Jeong S; Kim S; Song KS; Park JH; Heo JY; Seo KS; Park SK; Kweon GR; Wu T; Park JI; Lim K
Cell Death Dis; 2014 Nov; 5(11):e1524. PubMed ID: 25393480
[TBL] [Abstract][Full Text] [Related]
5. Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.
Conrady MC; Suarez I; Gogl G; Frecot DI; Bonhoure A; Kostmann C; Cousido-Siah A; Mitschler A; Lim J; Masson M; Iftner T; Stubenrauch F; Travé G; Simon C
J Virol; 2020 Dec; 95(2):. PubMed ID: 33115863
[TBL] [Abstract][Full Text] [Related]
6. E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78.
Ajiro M; Zheng ZM
mBio; 2015 Feb; 6(1):e02068-14. PubMed ID: 25691589
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor.
Huh K; Zhou X; Hayakawa H; Cho JY; Libermann TA; Jin J; Harper JW; Munger K
J Virol; 2007 Sep; 81(18):9737-47. PubMed ID: 17609271
[TBL] [Abstract][Full Text] [Related]
9. Viral oncoproteins and ubiquitination: accessing a cellular toolbox for modifying protein function.
Thomas M; Banks L
FEBS J; 2017 Oct; 284(19):3168-3170. PubMed ID: 28972311
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation.
Jeong KW; Kim HZ; Kim S; Kim YS; Choe J
Oncogene; 2007 Jan; 26(4):487-99. PubMed ID: 16878151
[TBL] [Abstract][Full Text] [Related]
11. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.
Chiang C; Pauli EK; Biryukov J; Feister KF; Meng M; White EA; Münger K; Howley PM; Meyers C; Gack MU
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263274
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin ligase E6AP mediates nonproteolytic polyubiquitylation of β-catenin independent of the E6 oncoprotein.
Kuslansky Y; Sominsky S; Jackman A; Gamell C; Monahan BJ; Haupt Y; Rosin-Arbesfeld R; Sherman L
J Gen Virol; 2016 Dec; 97(12):3313-3330. PubMed ID: 27902311
[TBL] [Abstract][Full Text] [Related]
13. USP15 inhibits HPV16 E6 degradation and catalytically inactive USP15 has reduced inhibitory activity.
Yaginuma Y; Yoshimoto M; Tokuda A
Acta Virol; 2018; 62(2):147-156. PubMed ID: 29895155
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
[TBL] [Abstract][Full Text] [Related]
15. Interaction of HPV E6 oncoproteins with specific proteasomal subunits.
Tomaić V; Ganti K; Pim D; Bauer C; Blattner C; Banks L
Virology; 2013 Nov; 446(1-2):389-96. PubMed ID: 24074603
[TBL] [Abstract][Full Text] [Related]
16. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.
Drews CM; Brimer N; Vande Pol SB
PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase.
Kao WH; Beaudenon SL; Talis AL; Huibregtse JM; Howley PM
J Virol; 2000 Jul; 74(14):6408-17. PubMed ID: 10864652
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of genes involved in keratinocyte differentiation by human papillomavirus 16 oncoproteins.
Gyöngyösi E; Szalmás A; Ferenczi A; Póliska S; Kónya J; Veress G
Arch Virol; 2015 Feb; 160(2):389-98. PubMed ID: 25488293
[TBL] [Abstract][Full Text] [Related]
19. Functional interaction between human papillomavirus type 16 E6 and E7 oncoproteins and cigarette smoke components in lung epithelial cells.
Muñoz JP; González C; Parra B; Corvalán AH; Tornesello ML; Eizuru Y; Aguayo F
PLoS One; 2012; 7(5):e38178. PubMed ID: 22662279
[TBL] [Abstract][Full Text] [Related]
20. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
